A China A-share quantitative strategy that dynamically rotates regime-specific signals to generate high-Sharpe excess returns over the CSI A500.
Philippine Seven as a high-quality 7-Eleven franchise operator offering durable Southeast Asian consumer growth, attractive cash flow, and valuation recovery potential.
A hedged long Modern Dental / short Hang Seng Index trade targeting global dental-prosthetics growth and a market mispricing of its digital operating leverage.
Alphabet as an underappreciated AI platform combining dominant digital entry points, frontier models, cloud infrastructure, proprietary TPUs, and Waymo optionality.
A hedged Nasdaq-100 options strategy that sells expensive short-dated volatility to finance long convexity and retain upside participation with lower drawdown risk.
Clinical-stage cardiovascular biotech focused on EDG-7500 for HCM and EDG-15400 for HFpEF, with a cleaner, well-capitalized platform after the Servier transaction.
China’s integrated new-materials platform, spanning specialty plastics for AI and robotics, with high-margin growth obscured by its legacy commodity businesses.
Chinese innovative drugs approaching the “strike zone” — fundamentals improving and risk becoming more predictable, while valuations remain near historical lows.
El Niño CTA: Long palm oil & natural rubber with soybean oil hedge, targeting delayed supply shocks in Southeast Asia.
PRESENTED BY
